NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
Core-Mark Holding Company, Inc. (NASDAQ: CORE)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Performance Food Group Company. Under the terms of the merger, Core-Mark shareholders will receive $23.875 per share in cash and 0.44 Performance Food shares for each Core-Mark share. Upon closing, Core-Mark shareholders will own approximately 13% of the combined company.
If you are a Core-Mark shareholder,
click here to learn more about your rights and options
.
Cabot Oil & Gas Corporation (NYSE: COG)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Cimarex Energy Co. Cimarex Energy shareholders will receive Cabot Oil & Gas common stock in connection with the merger. Upon completion of the transaction, Cabot Oil & Gas shareholders will own approximately 49.5% of the combined company on a fully diluted basis.
If you are a Cabot Oil shareholder,
click here to learn more about your rights and options
.
Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Aadi Bioscience, Inc. Under the merger, Aadi shareholders will receive newly issued shares of Aerpio common stock. On a pro forma basis, Aerpio shareholders will own approximately 33.2% of the combined company upon the closing of the merger prior to the additional PIPE financing transaction. Following the closing of the concurrent PIPE financing, Aerpio shareholders will own approximately 14.7% of the combined company.
If you are an Aerpio shareholder,
click here to learn more about your rights and options
.
Strongbridge Biopharma plc (NASDAQ: SBBP)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Xeris Pharmaceuticals, Inc. Under the terms of the merger, Strongbridge shareholders will receive 0.7840 shares of the combined company and 1 contingent value right (“CVR”) for each Strongbridge share that they own. The CVR is worth up to $1.00 in cash or stock of the combined company upon achievement of certain triggering events.
If you are a Strongbridge shareholder,
click here to learn more about your rights and options
.
Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm
free of charge
to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email
[email protected]
or
[email protected]
.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
